Cell transplantation for patients with Parkinson's disease
1Neuronal Survival Unit, Experimental Medical Sciences, Wallenberg Neurocentrum, University of Lund, BMC A10, 22184 Lund, Sweden. gesine.paul@mphy.lu.se
Abstract:
This chapter focuses on cell replacement therapies in Parkinson's disease (PD) and describes experimental data leading to clinical trials, as well as the methodology and efficacy of grafts of human embryonic nigral tissue in patients with PD. It also highlights some of the clinical problems the procedure presents and considers future alternative sources of donor tissue, including various forms of stem cells.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
EPS and iPS Cells in Disease Research
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Parkinson Disease l: Introduction


